Fibres/Yarns
Drug loaded fibres launched
Drugs incorporated in the fibre at the time of extrusion enable implantable medical devices to meet demanding performance requirements using commercially available polymers such as PLLA, PGA, PLGA and PDO and customers’ proprietary materials for specific applications
10th April 2013
Knitting Industry
|
Dallas, TX
TissueGen Inc., a developer of cutting-edge biodegradable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, has announced the availability of its Elute biodegradable drug-loaded fibre products, including pharmaceutical loaded fibres and growth factor loaded fibres. The new drug-loaded fibres are said to be ideally suited for conversion to knitted, woven or braided textiles.
TissueGen’s core technology includes patented processes for extrusion of biodegradable drug-loaded fibres at room temperature. The innovative process is said to preserve the biological activity of incorporated drugs and therapeutic agents, thereby enabling drug delivery and sustained therapeutic release through implantable medical devices.
Business intelligence for the fibre, textiles and apparel industries: technologies, innovations, markets, investments, trade policy, sourcing, strategy...
Find out more
